Compared to IL-2-treated mice, P-IL-2-treated mice exhibited slowed tumor growth, as well as a relative decrease in regulatory T cells and a relative increase in CD8+ T cells in the immune microenvironment. This evidence concerns the gene IL2 and neoplasm.